Page last updated: 2024-08-17

isosorbide dinitrate and dihydropyridines

isosorbide dinitrate has been researched along with dihydropyridines in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kähönen, M; Kööbi, T; Nieminen, T; Turjanmaa, V; Ylitalo, P; Ylitalo, R1
Endo, T; Gohbara, M; Kimura, K1

Trials

1 trial(s) available for isosorbide dinitrate and dihydropyridines

ArticleYear
Effects of a mononitrate, a beta1-blocker and a dihydropyridine calcium channel blocker on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study in normotensive volunteers.
    Arzneimittel-Forschung, 2005, Volume: 55, Issue:3

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Female; Hemodynamics; Humans; Hypotension, Orthostatic; Isosorbide Dinitrate; Male; Nisoldipine; Nitric Oxide Donors; Supine Position; Tilt-Table Test

2005

Other Studies

2 other study(ies) available for isosorbide dinitrate and dihydropyridines

ArticleYear
Sustained-release nifedipine: new indication. Angina: safer drugs are available.
    Prescrire international, 1998, Volume: 7, Issue:35

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Delayed-Action Preparations; Dihydropyridines; Diltiazem; Drug Evaluation; Female; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Nifedipine; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents

1998
A case of initial rhythm of pulseless electrical activity caused by vasospastic angina.
    International journal of cardiology, 2016, Nov-01, Volume: 222

    Topics: Angiocardiography; Cardiopulmonary Resuscitation; Coronary Angiography; Coronary Vasospasm; Dihydropyridines; Electrophysiologic Techniques, Cardiac; Heart Arrest; Humans; Isosorbide Dinitrate; Male; Middle Aged; Treatment Outcome; Vasodilator Agents

2016